Sales and Marketing

Showing 15 posts of 11524 posts found.

AstraZeneca fights generic Nexium bid

November 25, 2005 Sales and Marketing

AstraZeneca has filed a lawsuit in the US courts to block the launch of a generic version of Nexium.The ulcer …

Which company has the industry’s best R&D pipeline?

November 25, 2005 Sales and Marketing

Take part in Pharmafocus' industry poll on the leading product pipelinesThe pharma industry has experienced another turbulent year of change …

FDA clears Tamiflu in children after safety scare

November 22, 2005 Sales and Marketing

The FDA says there is no evidence that Tamiflu was linked to the death of 12 children taking the antiviral …

Amgen sues Roche over new anaemia treatment

November 22, 2005 Sales and Marketing

Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …

Asthma drug warning hits GlaxoSmithKline

November 21, 2005 Sales and Marketing

Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …

Which company is pharma’s rising star?

November 17, 2005 Sales and Marketing

Pharmaceutical executives are voting in their hundreds every week in a unique survey to find out which companies are the …

Patient demand brings Sativex to UK ahead of approval

November 17, 2005 Sales and Marketing GW Pharmaceuticals, Sativex

The unlicensed cannabis-based medicine Sativex will be available in the UK to treat neuropathic pain on a named patient basis …

Stricter new UK industry code of practice launched

November 16, 2005 Medical Communications, Sales and Marketing

The UK pharmaceutical industry is to adopt a new stricter code of conduct to help distance itself from allegations of …

Study results not IDEAL for Lipitor

November 16, 2005 Research and Development, Sales and Marketing

A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …

Herbal medicines must prove safety

November 10, 2005 Sales and Marketing

The marketing of herbal medicines will now face stricter regulation across the European Union following the introduction of new legislation. …

GSK loses out on UK Seroxat patent

November 10, 2005 Sales and Marketing

GlaxoSmithKline has been defeated in a long-running battle over the UK patent on its antidepressant Seroxat.After four years of legal …

MSD patient safety campaign tackles counterfeits

November 10, 2005 Sales and Marketing

Merck Sharp & Dohme has launched a public information campaign warning of the the dangers of buying 'lifestyle' drugs over …

New advertising checks could delay UK launches

November 10, 2005 Sales and Marketing

The MHRA has conceded that checks on advertising and promotional materials for new prescription medicines could delay their UK launch …

Bextra suspension confirmed in EU

November 9, 2005 Sales and Marketing

The European Commission has confirmed that Pfizer's Cox-II product Bextra will remain suspended from the market because of safety concerns.The …

Ebixa takes on Alzheimer’s market leaders

November 9, 2005 Sales and Marketing

Lundbeck's Alzheimer's treatment Ebixa will compete directly with the leading treatments for the moderate form of the disease following an …
The Gateway to Local Adoption Series

Latest content